Colorectal cancer metastasis: The dna repair inhibitor dbait increases sensitivity to hyperthermia and improves efficacy of radiofrequency ablation

Radiology

Volumn 270, Issue 3, 2014, Pages 736-746

  Devun, Flavien ^a,c   Biau, Julian ^a,d   Huerre, Michel ^a,e   Croset, Amélie ^a,b   Sun, Jian Sheng ^c,f   Denys, Alban ^h   Dutreix, Marie ^a,b,g  

^a INSTITUT CURIE   (France)

^b Centre National de la Recherche Scientifique   (France)

^c DNA Therapeutics   (France)

^d CENTRE JEAN PERRIN   (France)

^e INSTITUT PASTEUR   (France)

^f MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

^h LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOUBLE STRAND BREAK BAIT; HISTONE H2AX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CELL DEATH; CELL PROLIFERATION; COLON ADENOCARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; DNA DAMAGE; DNA REPAIR; DRUG EFFICACY; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERTHERMIA; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIOFREQUENCY ABLATION; SIGNAL TRANSDUCTION; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; CATHETER ABLATION; COLORECTAL NEOPLASMS; DNA DAMAGE; DNA REPAIR; HUMANS; HYPERTHERMIA, INDUCED; LIVER NEOPLASMS; MICE; OLIGODEOXYRIBONUCLEOTIDES; TUMOR CELLS, CULTURED;

EID: 84895474858     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13130805     Document Type: Article

References (43)

1. Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 2003;14(Suppl 2):ii13-ii16.
2. Padma S, Martinie JB, Iannitti DA. Liver tumor ablation: percutaneous and open approaches. J Surg Oncol 2009;100(8):619-634.
3. Itoh T, Orba Y, Takei H, et al. Immunohistochemical detection of hepatocellular carcinoma in the setting of ongoing necrosis after radiofrequency ablation. Mod Pathol 2002;15(2):110-115.
4. Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect. AJR Am J Roentgenol 2002;178(1): 47-51.
5. Montgomery RS, Rahal A, Dodd GD 3rd, Leyendecker JR, Hubbard LG. Radiofrequency ablation of hepatic tumors: variability of lesion size using a single ablation device. AJR Am J Roentgenol 2004;182(3):657-661.
6. Ahmad A, Chen SL, Kavanagh MA, Allegra DP, Bilchik AJ. Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better? Am Surg 2006;72(10):875-879.
7. Aloia TA, Vauthey JN, Loyer EM, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 2006;141(5):460-466; discussion 466-467.
8. Hur H, Ko YT, Min BS, et al. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg 2009;197(6):728-736.
9. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005;242(2):158-171.
10. Franckena M, van der Zee J. Use of combined radiation and hyperthermia for gynecological cancer. Curr Opin Obstet Gynecol 2010;22(1):9-14.
11. Hurwitz MD, Hansen JL, Prokopios-Davos S, et al. Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana- Farber Cancer Institute study 94-153. Cancer 2011;117(3):510-516.
12. De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, et al. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev 2009 (3):CD006269.
13. Krawczyk PM, Eppink B, Essers J, et al. Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proc Natl Acad Sci U S A 2011;108(24):9851-9856.
14. Quanz M, Berthault N, Roulin C, et al. Smallmolecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy. Clin Cancer Res 2009;15(4):1308-1316.
15. Quanz M, Chassoux D, Berthault N, Agrario C, Sun JS, Dutreix M. Hyperactivation of DNA-PK by double-strand break mimicking molecules disorganizes DNA damage response. PLoS ONE 2009;4(7):e6298.
16. Devun F, Bousquet G, Biau J, et al. Preclinical study of the DNA repair inhibitor Dbait in combination with chemotherapy in colorectal cancer. J Gastroenterol 2012;47(3):266-275.
17. Dangles-Marie V, Pocard M, Richon S, et al. Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. Cancer Res 2007;67(1):398-407.
18. Berthault N, Maury B, Agrario C, et al. Comparison of distribution and activity of nanoparticles with short interfering DNA (Dbait) in various living systems. Cancer Gene Ther 2011;18(10):695-706.
19. Yang WL, Nair DG, Makizumi R, et al. Heat shock protein 70 is induced in mouse human colon tumor xenografts after sublethal radiofrequency ablation. Ann Surg Oncol 2004;11(4): 399-406.
20. Guido M, Fassan M, Giacomelli L, et al. Micronuclei and broken eggs in human liver carcinogenesis. Anticancer Res 2008;28(4C): 2507-2511.
21. Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S. The HUman MicroNucleus Project- An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res 1999;428(1-2):271-283.
22. Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 2001;13(2):149-158.
23. Fan W, Li X, Zhang L, Jiang H, Zhang J. Comparison of microwave ablation and multipolar radiofrequency ablation in vivo using two internally cooled probes. AJR Am J Roentgenol 2012;198(1):W46-W50.
24. Ohmoto K, Yoshioka N, Tomiyama Y, et al. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas. J Gastroenterol Hepatol 2009;24(2):223-227.
25. Schmidt CR, Shires P, Mootoo M. Real-time ultrasound imaging of irreversible electroporation in a porcine liver model adequately characterizes the zone of cellular necrosis. HPB (Oxford) 2012;14(2):98-102.
26. Liapi E, Geschwind JF. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol 2007;25(8):978-986.
27. Head HW, Dodd GD 3rd, Bao A, et al. Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors. Radiology 2010;255(2):405-414.
28. Ahmed M, Lukyanov AN, Torchilin V, Tournier H, Schneider AN, Goldberg SN. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time. J Vasc Interv Radiol 2005;16(10):1365-1371.
29. Sugimori K, Nozawa A, Morimoto M, et al. Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model. J Vasc Interv Radiol 2005;16(6):849-856.
30. Mostafa EM, Ganguli S, Faintuch S, Mertyna P, Goldberg SN. Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors. J Vasc Interv Radiol 2008; 19(12):1740-1748.
31. Hines-Peralta A, Sukhatme V, Regan M, Signoretti S, Liu ZJ, Goldberg SN. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models. Radiology 2006;240(1):82-89.
32. Wu H, Exner AA, Krupka TM, Weinberg BD, Haaga JR. Vasomodulation of tumor blood flow: effect on perfusion and thermal ablation size. Ann Biomed Eng 2009;37(3):552-564.
33. Zhang YJ, Liang HH, Chen MS, et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology 2007; 244(2):599-607.
34. Hakimé A, Hines-Peralta A, Peddi H, et al. Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice. Radiology 2007;244(2): 464-470.
35. Ganapathy-Kanniappan S, Kunjithapatham R, Torbenson MS, et al. Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists. Radiology 2012;262(3): 834-845.
36. Bonomo G, Della Vigna P, Monfardini L, et al. Combined therapies for the treatment of technically unresectable liver malignancies: bland embolization and radiofrequency thermal ablation within the same session. Cardiovasc Intervent Radiol 2012;35(6):1372-1379.
37. Roti Roti JL. Heat-induced alterations of nuclear protein associations and their effects on DNA repair and replication. Int J Hyperthermia 2007;23(1):3-15.
38. Roti Roti JL, Pandita RK, Mueller JD, Novak P, Moros EG, Laszlo A. Severe, short-duration (0-3 min) heat shocks (50-52 degrees C) inhibit the repair of DNA damage. Int J Hyperthermia 2010;26(1):67-78.
39. van Gent DC, Hoeijmakers JH, Kanaar R. Chromosomal stability and the DNA doublestranded break connection. Nat Rev Genet 2001;2(3):196-206.
40. Bhardwaj N, Dormer J, Ahmad F, et al. Heat shock protein 70 expression following hepatic radiofrequency ablation is affected by adjacent vasculature. J Surg Res 2012;173(2): 249-257.
41. Zerbini A, Pilli M, Penna A, et al. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 2006;66(2):1139-1146.
42. Dromi SA, Walsh MP, Herby S, et al. Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology 2009; 251(1):58-66.
43. Weinberg BD, Blanco E, Lempka SF, Anderson JM, Exner AA, Gao J. Combined radiofrequency ablation and doxorubicin-eluting polymer implants for liver cancer treatment. J Biomed Mater Res A 2007;81(1):205-213.